Highlights
- Market Cap
- $336.36M
- Enterprise Value
- $462.61M
- EPS (TTM)
- $3.22
- PE Ratio
- 6.31
- PEG Ratio
- 0.19
- Total Revenue (TTM)
- $36.96M
- Gross Profit (TTM)
- $33.54M
- EBITDA (TTM)
- -$46.64M
- Year Range
- $14.89 - $50.44
- Target Price
- $61.00
- ROA (TTM)
- 8.10%
- ROE (TTM)
- 10.51%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Semler Scientific, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Semler Scientific, Inc.
- 1D
- —
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 32.96% | 32.96% | |||||||||||
| 2025 | -3.78% | -17.40% | -15.66% | -10.69% | 23.72% | -3.15% | -7.46% | -17.32% | 1.21% | -11.80% | -17.91% | -29.60% | -71.69% |
| 2024 | 0.00% | 6.50% | -38.08% | -12.60% | 14.88% | 17.29% | -3.63% | -19.46% | -11.80% | 24.76% | 94.08% | -5.30% | 21.92% |
| 2023 | 18.82% | -43.89% | 21.82% | 4.78% | -2.10% | -4.55% | -6.44% | 7.37% | -3.76% | 14.98% | 32.12% | 14.92% | 34.21% |
| 2022 | -17.44% | -3.53% | -32.11% | -7.20% | -39.42% | 1.15% | 10.11% | 47.31% | -17.85% | 11.88% | -29.45% | 11.34% | -63.99% |
| 2021 | -5.45% | 15.89% | 4.37% | 5.35% | -2.87% | 1.63% | 5.56% | -10.17% | 17.95% | 19.96% | -35.74% | -4.91% | -2.50% |
Benchmark Metrics
Semler Scientific, Inc. has an annualized alpha of 33.12%, beta of 0.99, and R² of 0.05 versus S&P 500 Index. Calculated based on daily prices since February 24, 2014.
- This stock participated in 111.39% of S&P 500 Index downside but only 99.02% of its upside — more exposed to losses than it benefited from rallies.
- R² of 0.05 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 33.12%
- Beta
- 0.99
- R²
- 0.05
- Upside Capture
- 99.02%
- Downside Capture
- 111.39%
Return for Risk
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Semler Scientific, Inc. (SMLR) and compare them to a chosen benchmark (S&P 500 Index).
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Semler Scientific, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Semler Scientific, Inc. was 89.86%, occurring on Dec 30, 2025. The portfolio has not yet recovered.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -89.86% | Nov 1, 2021 | 1045 | Dec 30, 2025 | — | — | — |
| -80.57% | Feb 27, 2014 | 589 | Jun 29, 2016 | 338 | Nov 1, 2017 | 927 |
| -44.5% | Feb 25, 2020 | 20 | Mar 23, 2020 | 91 | Jul 31, 2020 | 111 |
| -28.84% | Oct 4, 2018 | 37 | Nov 26, 2018 | 37 | Jan 22, 2019 | 74 |
| -27.6% | Aug 1, 2019 | 49 | Oct 9, 2019 | 90 | Feb 19, 2020 | 139 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Semler Scientific, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Semler Scientific, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for SMLR, comparing it with other companies in the Medical Devices industry. Currently, SMLR has a P/E ratio of 6.3. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for SMLR compared to other companies in the Medical Devices industry. SMLR currently has a PEG ratio of 0.2. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for SMLR relative to other companies in the Medical Devices industry. Currently, SMLR has a P/S ratio of 8.3. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for SMLR in comparison with other companies in the Medical Devices industry. Currently, SMLR has a P/B value of 0.7. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |